Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluid Management in Sickle Cell Disease Vaso-occlusive Crisis: Restrictive Versus Liberal Strategies: A Randomized Controlled Trial (FLASC Trial)

NCT07188766 is registered in ClinicalTrials.gov with Imam Abdulrahman Bin Faisal University as lead sponsor.

NCT NCT07188766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07188766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluid Management in Sickle Cell Disease Vaso-occlusive Crisis: Restrictive Versus Liberal Strategies: A Randomized Controlled Trial (FLASC Trial)
Lead sponsor
Imam Abdulrahman Bin Faisal University
Phase
Not applicable
Overall status
Recruiting
Start date
October 5, 2025
Completion date
October 31, 2028
Enrollment
394 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

scd, vaso occlussive crisis